Is leflunomide effective in the treatment of psoriasis in a patient who is unable to benefit from standard first- and second-line therapies and needs an affordable treatment option?

Andrew Graeme Affleck; Hywel Williams

doi:10.1001/archdermatol.2008.502

Is leflunomide effective in the treatment of psoriasis in a patient who is unable to benefit from standard first- and second-line therapies and needs an affordable treatment option?

Andrew Graeme Affleck, Hywel Williams

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1642-1643
Number of pages	2
Journal	Archives of Dermatology
Volume	144
Issue number	12
DOIs	https://doi.org/10.1001/archdermatol.2008.502
Publication status	Published - 15 Dec 2008

Keywords

Evidence-Based Medicine
Humans
Immunosuppressive Agents
Isoxazoles
Male
Psoriasis
Randomized Controlled Trials as Topic
Young Adult

Access to Document

10.1001/archdermatol.2008.502

http://archderm.jamanetwork.com/journal.aspx

Cite this

@article{2c8971e22e3649feb1a1e4cd9b2a628d,

title = "Is leflunomide effective in the treatment of psoriasis in a patient who is unable to benefit from standard first- and second-line therapies and needs an affordable treatment option?",

keywords = "Evidence-Based Medicine, Humans, Immunosuppressive Agents, Isoxazoles, Male, Psoriasis, Randomized Controlled Trials as Topic, Young Adult",

author = "Affleck, {Andrew Graeme} and Hywel Williams",

year = "2008",

month = dec,

day = "15",

doi = "10.1001/archdermatol.2008.502",

language = "English",

volume = "144",

pages = "1642--1643",

journal = "Archives of Dermatology",

issn = "0003-987X",